Medication info
Robasto Tablet 20mg (Rosuvastatin Calcium)

Robasto Tablet 20mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
HLB Pharmaceuticals Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202000660 · Approved 2020.02.05 · Insurance code 647304070

Summary

Main use
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this product and continue it throughout the treatment period. This product may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this product to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with use in patients with a Child-Pugh score above 9. Do not administer this product to patients with active liver disease. 6. Race: Because systemic exposure to this product is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Children's dosage
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
HLB Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease

  • Hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerosis
  • dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL-cholesterol levels
  • smoking
  • family history of early coronary heart disease
View approved original text

This medication is used in patients with primary hypercholesterolemia and mixed dyslipidemia who have difficulties controlling their condition through diet and exercise alone. It is also used as an adjunct therapy in patients with homozygous familial hypercholesterolemia who are are under dietary therapy or another lipid-lowering treatment. This medication effectively lowers total cholesterol and LDL-cholesterol levels, delaying the progression of atherosclerosis. It is also used as an adjunct to dietary therapy in children aged 10 to 17 years with heterozygous familial hypercholesterolemia who have elevated LDL-cholesterol levels or cardiovascular disease risk factors. It plays a supporting role in dietary therapy for patients with primary dysbetalipoproteinemia. Particularly, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in adults with elevated high-sensitivity C-reactive protein levels. Thus, this medication is effectively used to improve patients' blood lipid levels and reduce cardiovascular disease risk.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this product and continue it throughout the treatment period. This product may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this product to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with use in patients with a Child-Pugh score above 9. Do not administer this product to patients with active liver disease. 6. Race: Because systemic exposure to this product is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Children's dosage

Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For example, patients with allergies to any components of this medication, those with severe liver dysfunction, patients with muscle disorders, those with significantly impaired kidney function, pregnant or breastfeeding women, and women of childbearing age who are not using appropriate contraceptives should not take this medication. Since this medication can affect muscles, caution is needed for patients at high risk of muscle pain or myopathy. Such patients include those with decreased kidney function, hypothyroidism, a history of genetic muscle disorders, alcohol abuse, and the elderly. If symptoms such as muscle pain, muscle weakness, cramps, fatigue, or fever appear during use, immediate medical attention should be sought for examination. If these symptoms are severe or if blood test results are abnormal, discontinuation of the medication may be necessary. This medication can affect liver function, so it is essential to regularly monitor liver function before and during treatment. If symptoms of liver damage or jaundice occur, medication should be discontinued immediately. Additionally, this medication can affect blood sugar levels, so patients at risk for diabetes should regularly monitor their blood sugar. This medication can interact with other drugs, so if you are currently taking other medications, make sure to inform your healthcare provider. In particular, concurrent use with certain antivirals, immunosuppressants, some antibiotics, and fibrates may increase the risk of muscle damage. Pregnant or breastfeeding women should avoid this medication, and women with the possibility of pregnancy must use appropriate contraceptive methods. In the case of overdose, there is no specific antidote, so treatment should be managed according to the symptoms along with monitoring liver and muscle enzyme levels. Dizziness may occur with this medication, so caution is advised when driving or operating machinery. Finally, since this medication contains lactose, patients with lactose intolerance should avoid it.

Side effects

Angioedema, hypersensitivity reaction, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms (DRESS), eczema-like drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, fatigue, numbness, paraesthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, gout, erectile dysfunction, joint pain, acute kidney failure, oliguria, elevated serum creatinine

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.